98%
921
2 minutes
20
Objectives: To evaluate the efficacy of the O-RADS MRI criteria in the stratification of risk of malignancy of solid or sonographically indeterminate ovarian masses and assess the interobserver agreement of this classification between experienced and inexperienced radiologists.
Methods: This single-centre retrospective study included patients from 2019 to 2022 with sonographically indeterminate or solid ovarian masses who underwent MRI with a specific protocol for characterisation according to O-RADS MRI specifications. Each study was evaluated using O-RADS lexicon by two radiologists, one with 17 years of experience in gynaecological radiology and another with 4 years of experience in general radiology. Findings were classified as benign, borderline, or malignant according to histology or stability over time. Diagnostic performance and interobserver agreement were assessed.
Results: A total of 183 patients with US indeterminate or solid adnexal masses were included. Fifty-seven (31%) did not have ovarian masses, classified as O-RADS 1. The diagnostic performance for scores 2-5 was excellent with a sensitivity, specificity, PPV, and NPV of 97.4%, 100%, 96.2%, and 100%, respectively by the experienced radiologist and 96.1%, 92.0%, 93.9%, and 94.8% by the inexperienced radiologist. Interobserver concordance was very high (Kappa index 0.92). Almost all the misclassified cases were due to misinterpretation of the classification similar to reports in the literature.
Conclusion: The diagnostic performance of O-RADS MRI determined by either experienced or inexperienced radiologists is excellent, facilitating decision-making with high diagnostic accuracy and high reproducibility. Knowledge of this classification and use of assessment tools could avoid frequent errors due to misinterpretation.
Critical Relevance Statement: Up to 31% of ovarian masses are considered indeterminate by transvaginal US and 32% of solid lesions considered malignant by transvaginal US are benign. The O-RADs MRI accurately classifies these masses, even when used by inexperienced radiologists, thereby avoiding incorrect surgical approaches.
Key Points: • O-RADS MRI accurately classifies indeterminate and solid ovarian masses by ultrasound. • There is excellent interobserver agreement between experienced and non-experienced radiologists. • O-RADS MRI is a helpful tool to assess clinical decision-making in ovarian tumours.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11014836 | PMC |
http://dx.doi.org/10.1186/s13244-024-01670-3 | DOI Listing |
Abdom Radiol (NY)
August 2025
Tehran University of Medical Sciences, Tehran, Iran.
Background: Integrating diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) measurements with existing MR imaging protocols improves the differentiation between benign and malignant adnexal lesions. We aimed to assess the additional value of quantitative ADC in diagnosing adnexal masses classified by the O-RADS-MRI score and evaluate the impact on diagnostic performance.
Methods: This retrospective cohort study analyzed 159 patients with 218 ovarian masses, classified into benign, borderline, and malignant groups via histopathological evaluation.
Insights Imaging
July 2025
Department of Radiology, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, 400030, People's Republic of China.
Objectives: To develop an MRI-based radiomics model for ovarian masses categorization and to compare the model performance to Ovarian-Adnexal Reporting and Data System (O-RADS) and radiologists' assessments.
Materials And Methods: This retrospective multicenter study included 497 patients (249 benign, 248 malignant) allocated to training, internal, and external validation sets (293/124/80 masses, respectively). Radiomics features were extracted from preoperative MRI.
Cureus
June 2025
Department of Diagnostic and Interventional Radiology, All India Institute of Medical Sciences, Rishikesh, IND.
The Ovarian-Adnexal Reporting and Data System magnetic resonance imaging (O-RADS MRI) is a standardized risk stratification system designed to enhance uniform interpretation and reporting of adnexal masses on MRI. A PubMed search was conducted using the keyword "O-RADS MRI," yielding 61 articles in the search results. After excluding eight articles, 53 articles were selected.
View Article and Find Full Text PDFArch Gynecol Obstet
July 2025
Department of Obstetrics and Gynecology, Health Sciences University Istanbul Kanuni Sultan Süleyman Training and Research Hospital, Istanbul, Turkey.
Purpose: Adnexal masses (AMs) are commonly seen gynecological problems. Most of the AMs of women in reproductive period are physiologic. A rare but lethal cause of AMs is ovarian cancer.
View Article and Find Full Text PDFIntroduction Accurate characterization of ovarian lesions is essential for guiding clinical management, influencing decisions on conservative follow-up, medical treatment, or surgical intervention. The Ovarian-Adnexal Reporting and Data System (O-RADS) has emerged as a standardized tool for risk stratification, aiming to improve diagnostic accuracy and management of ovarian adnexal pathologies. This study aimed to compare the diagnostic performance of ultrasonography (USG) and magnetic resonance imaging (MRI) in evaluating ovarian lesions using the O-RADS classification system.
View Article and Find Full Text PDF